Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
Moleculin(US:MBRX) Prnewswire·2024-05-01 12:50– Company appoints internationally renowned clinician, Martin S. Tallman, MD as inaugural clinician memberHOUSTON, May 1, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the formation of its Annamycin Scientific Advisory Board and inaugural appointment of Dr. Martin Tallman. Dr. Tallman is an internationally renowned clini ...